Company Interview / Vitura dialling into Australia's healthcare shift

Key topics:

Surge in telehealth usage among Australians Emphasis on cost, convenience, and flexible appointmentsVitura Health’s acquisition of Candor and new platform launch Rising interest in medicinal cannabis and alternative therapies

Australians are rapidly shifting away from traditional GP visits, according to CEO, Geoff Cockerill of Vitura Health (ASX:VIT), as telehealth options gain traction for their flexibility and convenience. Cockerill states that the demand for telehealth is climbing, particularly among younger people and families, who value the ability to select appointment times, avoid clinic travel, and enjoy video consultations that replicate in-person doctor visits.

Cockerill highlights a significant trend: patients are increasingly balancing cost with convenience, leading to sustained growth in the telehealth sector. Vitura Health's Doctors on Demand platform reportedly sees high demand, reflecting broader changes in consumer preferences. The business aims to keep pace by continually recruiting doctors and healthcare professionals to match the robust growth.

Cockerill points to Vitura Health's (ASX:VIT) recent acquisition of Candor, which operates in emerging therapies such as medicinal cannabis, as a key expansion. The updated Candor platform, launched this week, is part of Vitura’s focus on quality and regulation in alternative therapies. Cockerill foresees a positive long-term outlook for both telehealth and alternative therapy markets, driven by strict standards and the shift towards personalised, accessible care.